XOMA Royalty (XOMA) Depreciation & Amortization (CF) (2010 - 2021)
XOMA Royalty (XOMA) reported Depreciation & Amortization (CF) of $2000.0 for Q3 2021, down 71.43% on a YoY basis from $7000.0 in Q3 2020, and little changed sequentially from $2000.0 in Q2 2021.
XOMA Royalty (XOMA) Depreciation & Amortization (CF) (2010 - 2021) Analysis & Trends
XOMA Royalty (XOMA) has 12 years of Depreciation & Amortization (CF) data on file, last reported at $2000.0 in Q3 2021.
- For the quarter ending Q3 2021, Depreciation & Amortization (CF) fell 71.43% year-over-year to $2000.0; the trailing twelve-month figure through Jun 2022 stood at $2000.0 (down 85.71% YoY), and the FY2020 full-year result was $22000.0, down 12.0% from the prior year.
- Depreciation & Amortization (CF) was little changed at $2000.0 in Q3 2021, from $2000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $147000.0 in Q1 2017 to a low of $2000.0 in Q1 2021.
- A 5-year average of $20368.4 and a median of $7000.0 in 2018 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) slumped 94.56% in 2018 and changed 0.0% in 2020, its largest moves.
- Tracing XOMA's Depreciation & Amortization (CF) over 5 years: stood at $15000.0 in 2017, then slumped by 53.33% to $7000.0 in 2018, then declined by 14.29% to $6000.0 in 2019, then tumbled by 50.0% to $3000.0 in 2020, then sank by 33.33% to $2000.0 in 2021.
- Business Quant data shows XOMA's Depreciation & Amortization (CF) at $2000.0 in Q3 2021, $2000.0 in Q2 2021, and $2000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Mar 31, 2021 | 2,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Mar 31, 2020 | 6,000.00 |
| Mar 31, 2020 | 6,000.00 |
| Dec 31, 2019 | 6,000.00 |
| Dec 31, 2019 | 6,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Sep 30, 2019 | 7,000.00 |
| Jun 30, 2019 | 6,000.00 |
| Jun 30, 2019 | 6,000.00 |